NRSN
Neurosense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$6.66
−0.97%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-58.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 17, 2026 | Eisenberg Or · officer: Chief Financial Officer | Purchase | 250,000 | $0.80 |
| Jun 17, 2026 | Ben-Noon Alon · officer: Chief Executive Officer | Purchase | 250,000 | $0.80 |
| Mar 30, 2026 | Russek-Blum Niva · officer: Chief Technology Officer | A-Award | 200,000 | $0.00 |
| Mar 30, 2026 | Binder Hagit · officer: General Manager | A-Award | 200,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 5Increased 3Reduced 5Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| UBS Group AG | Increased | 108,636 | Aug 13, 2026 |
| Independent Advisor Alliance | Increased | 100,000 | Aug 12, 2026 |
| Yorkville Advisors Global, LP | Unchanged | 78,000 | Aug 6, 2026 |
| YORKVILLE ADVISORS GLOBAL, LP | Reduced | 78,000 | May 13, 2026 |
| INDEPENDENT ADVISOR ALLIANCE | New Position | 50,000 | May 12, 2026 |
| UBS GROUP AG | Increased | 49,096 | May 5, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 44,445 | May 15, 2026 |
| MEITAV INVESTMENT HOUSE LTD | Unchanged | 40,000 | Apr 29, 2026 |
| JANE STREET GROUP, LLC | New Position | 28,670 | May 12, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | Unchanged | 22,775 | Jul 29, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | Unchanged | 22,775 | Apr 27, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | Unchanged | 21,150 | Aug 7, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | New Position | 21,150 | May 8, 2026 |
| Pathstone Holdings, LLC | Unchanged | 16,528 | Aug 13, 2026 |
| PATHSTONE HOLDINGS, LLC | Unchanged | 16,528 | May 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 17, 2026